Royal Bank of Canada to repurchase up to 20 million common shares

TORONTO, Oct. 29 /CNW/ - Royal Bank of Canada (RY on TSX and NYSE) today announced that the Toronto Stock Exchange has approved its normal course issuer bid to purchase, for cancellation, up to 20 million of its common shares through the facilities of the Toronto Stock Exchange.

The purchase of common shares under the normal course issuer bid forms part of RBC's capital management program and will enable the bank to balance the imperatives of maintaining strong capital ratios with the ongoing need to generate shareholder value.

The shares that may be repurchased represent approximately 1.4 per cent of the bank's outstanding common shares. As of October 21, 2009, there were 1,417,573,298 common shares of the bank outstanding.

Purchases under the normal course issuer bid may commence on November 1, 2009, and will terminate on October 31, 2010. The bank will only initiate purchases under the bid after consulting with the Office of the Superintendent of Financial Institutions (OSFI). The price paid for any repurchased shares will be the market price of such shares on the TSX at the time of acquisition. The average daily trading volume of the Bank's shares on the Toronto Stock Exchange for the 6 months ended September 30, 2009, calculated in accordance with the rules of the Toronto Stock Exchange for the purposes of the bid, was 4,290,093 shares.

As of October 21, 2009, the bank had not purchased any common shares under the bank's current normal course issuer bid, which will expire on October 31, 2009.

SOURCE RBC

For further information: For further information: Investor contact: Alethea Rasquinha, (416) 955-7807; Media contact: Stephanie Lu, (416) 974-5506


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890